Repositioning Candidate Details

Candidate ID: R0872
Source ID: DB05787
Source Type: investigational
Compound Type: biotech
Compound Name: LM-609
Synonyms: --
Molecular Formula: --
SMILES: --
DrugBank Description: LM-609 (Vitaxin) is an artificial antibody that targets a protein on the surface of newly forming blood vessels, as well as on certain tumors. In addition to cancer, the protein has been implicated in bone destruction in rheumatoid arthritis and the inflammatory process in psoriasis.
CAS Number: --
Molecular Weight:
DrugBank Indication: Investigated for use/treatment in colorectal cancer, melanoma, prostate cancer, psoriasis and psoriatic disorders, rheumatoid arthritis, and solid tumors.
DrugBank Pharmacology: --
DrugBank MoA: LM-609 targets the alpha-v beta-3 integrin, which is a protein complex expressed on the surface of newly forming blood vessels, certain tumor types, and on a number of other cell types, including macrophages and osteoclasts. As such, alpha-v beta-3 integrin is implicated in a number of disease processes, including the growth and metastasis of tumors, the bone destruction in RA and the inflammatory process in psoriasis.
Targets: Integrin beta-3
Inclusion Criteria: Therapeutic strategy associated